Acquired CD20 Loss as a Mechanism of Resistance to Mosunetuzumab in Relapsed Follicular Lymphoma . Mediterranean Journal of Hematology and Infectious Diseases, [S. l.], v. 18, n. 1, p. e2026014, 2026. DOI: 10.4084/MJHID.2026.014. Disponível em: https://www.mjhid.org/mjhid/article/view/6199. Acesso em: 9 jun. 2026.